NASDAQ: COEPCoeptis Therapeutics Holdings Revenue
Coeptis Therapeutics Holdings revenue was $1.36M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $862.0k, up 263.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, COEP annual revenue was $1.4M, with Infinity% growth year-over-year.
COEP past revenue growth
How has COEP's revenue growth performed historically?
Company
N/A
Industry
468.23%
Market
88.78%
COEP's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
COEP's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
COEP revenue history
Current Revenue
$1.4M
Current Earnings
-$11.9M
Current Profit Margin
-874.3%
Be the first to know when COEP announces revenue.
COEP Revenue History By Year
| COEP Yearly Revenue | COEP Revenue | COEP Change | COEP Revenue Growth |
|---|---|---|---|
| 2025-12-31 | $1.36M | N/A | N/A |
| 2024-12-31 | $0.00 | N/A | N/A |
| 2023-12-31 | $0.00 | N/A | N/A |
| 2022-12-31 | $0.00 | -$75.00k | -100.00% |
| 2021-12-31 | $75.00k | $44.24k | +143.82% |
| 2020-12-31 | $30.76k | N/A | N/A |
| 2019-12-31 | $0.00 | N/A | N/A |
Coeptis Therapeutics Holdings Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.